AVS Bio, a portfolio company of Arlington Capital Partners, has acquired Biorbyt, a Cambridge, UK-based supplier of research antibodies, proteins, and other biomaterials. The acquisition expands AVS Bio’s product catalog and international distribution capabilities while adding an established e-commerce platform serving pharmaceutical companies, biotechnology businesses, and academic institutions. Financial terms were not disclosed.
